Vaddi, K., Verstovsek, S., & Kiladjian, J. (2016). Ruxolitinib: A targeted treatment option for patients with polycythemia vera. Blood Lymphat Cancer.
استشهاد بنمط شيكاغوVaddi, Kris, Srdan Verstovsek, و Jean-Jacques Kiladjian. "Ruxolitinib: A Targeted Treatment Option for Patients With Polycythemia Vera." Blood Lymphat Cancer 2016.
MLA استشهادVaddi, Kris, Srdan Verstovsek, و Jean-Jacques Kiladjian. "Ruxolitinib: A Targeted Treatment Option for Patients With Polycythemia Vera." Blood Lymphat Cancer 2016.
تحذير: قد لا تكون هذه الاستشهادات دائما دقيقة بنسبة 100%.